Related Experiment Videos
Comparative evaluation of three mammalian cell transformation assay systems
Summary
This study evaluated three cell transformation assays for chemical toxicity testing. While assays responded to carcinogens, limitations in reproducibility and dose-response effects prevent routine use for genetic toxicity screening.
Area of Science:
- Toxicology
- Cell Biology
- Genetics
Background:
- Cell transformation assays are crucial for predicting chemical carcinogenicity.
- Standardization and interlaboratory reproducibility are key for assay validation.
Purpose of the Study:
- To assess the intra- and interlaboratory reproducibility of three distinct cell transformation assay systems.
- To establish a basis for objective comparisons between the Syrian hamster embryo (SHE) cellular transformation assay, SHE/Simian adenovirus type 7 (SA7), and Rat/Rauscher leukemia virus (RLV) systems.
- To evaluate the performance of these assays in detecting chemical-induced genetic toxicity.
Main Methods:
- Three transformation assay systems were used: Syrian hamster embryo (SHE) primary cells, SHE infected with Simian adenovirus type 7 (SHE/SA7), and a rat fibroblast cell line (2FR450) infected with Rauscher leukemia virus (Rat/RLV).
- Nine "model" and five coded chemicals were tested across eight collaborating laboratories.
- Each system's endpoint for positive response was defined, and results were analyzed for reproducibility and dose-response relationships.
Main Results:
- All assay systems demonstrated a response to known carcinogens, with qualitative reproducibility observed across laboratories.
- Significant differences were noted in the assays' ability to show dose-related effects.
- Assay performance was inconsistent, often requiring multiple tests or modified procedures for adequate chemical evaluation.
Conclusions:
- Current limitations in scoring, reagent influence, and response reproducibility hinder the routine application of these assays for chemical testing.
- Further research is needed to overcome technical and procedural challenges before these systems can be reliably used for genetic toxicity screening.
- Standardization and refinement are essential for advancing cell transformation assays in toxicological risk assessment.